Publications
We aim to publish our findings in leading peer-reviewed journals. Follow this page for updates.
Patent for non-invasive prenatal diagnosis of autosomal recessive disorders.
Patent
SCHUH A. and Henderson S.
Clinical-grade validation of whole genome sequencing reveals robust detection of low-frequency variants and copy number alterations in CLL
Journal article
Klintman J. et al, British Journal of Haematology
Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis.
Journal article
Kaisaki PJ. et al, (2016), PLoS One, 11
TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics.
Journal article
Campo E. et al, (2018), Haematologica, 103, 1956 - 1968
Linking genotype to clinical phenotype through proteomic analysis of CLL trial samples
Conference paper
Eagle G. et al, (2017), LEUKEMIA & LYMPHOMA, 58, 100 - 101
The initial report of the bloodwise tap clarity study combining ibrutinib and venetoclax in relapsed, refractory CLL shows acceptable safety and promising early indications of efficacy
Conference paper
Munoz-Vicente S. et al, (2017), LEUKEMIA & LYMPHOMA, 58, 239 - 239
Patients' Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice Experiment.
Journal article
Buchanan J. et al, (2016), Patient, 9, 525 - 536
Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
Journal article
Fernandez-Mercado M. et al, (2013), Haematologica, 98, 1856 - 1864
Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia.
Journal article
Oscier D. et al, (2012), Br J Haematol, 159, 541 - 564
Screening for clinically significant non-deletional alpha thalassaemia mutations by pyrosequencing.
Journal article
Haywood A. et al, (2010), Ann Hematol, 89, 1215 - 1221
Incidence of haemoglobinopathies in various populations - the impact of immigration.
Journal article
Henderson S. et al, (2009), Clin Biochem, 42, 1745 - 1756
ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis.
Journal article
Schuh AH. et al, (2005), Mol Cell Biol, 25, 10235 - 10250
Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal article
Chanan-Khan AA. et al, (2017), Lancet Haematol, 4, e534 - e543
Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL.
Journal article
Howard DR. et al, (2017), Leukemia, 31, 2416 - 2425
Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.
Journal article
Parker H. et al, (2016), Leukemia, 30, 2179 - 2186
Progressive multifocal leukoencephalopathy as the presenting feature of chronic lymphocytic leukaemia.
Journal article
Bruce DR. et al, (2014), Br J Haematol, 167, 570 - 571
Issues surrounding the health economic evaluation of genomic technologies.
Journal article
Buchanan J. et al, (2013), Pharmacogenomics, 14, 1833 - 1847
Ofatumumab in advanced stage chronic lymphocytic leukaemia: results of the UK named patient compassionate use programme.
Journal article
Chowdhury O. et al, (2011), Br J Haematol, 155, 519 - 521
Quantitation of leukemic stem cell populations predicts clinical outcome in Acute Myeloid Leukaemia
Conference paper
Craddock CF. et al, (2011), Blood -New York-, 118, 292 - 292
MicroRNA expression in chronic lymphocytic leukaemia.
Journal article
Lawrie CH. et al, (2009), Br J Haematol, 147, 398 - 402